Quote:
Originally Posted by stylez2k4
This doesn't sound right to me. I had a look at the package insert for Shingrix that was approved in 2017:
and MenQuadfi (2020):
and DENGVAXIA (2019):
What certification are you talking about? Are you referring to approval?
Well yeah the disease has only been around 1 year. I'm not sure what long term date you are expecting...
|
In regards to the Dengvaxia vaccine, their trials used basically half of the amount of people the Pfizer vaccine did with an incredibly small, specific test group, as it looks like the vaccine can only be provided to people who have clinically tested for Dengue in the past.
Every approval varries greatly, obviously, and your shinrex comparison is apt. However they are obviously addressing completely different things which have completely different circumstances and potential outcomes.
As I said in the other post, certification and approval is based on what you are claiming your product does.